News & Videos - DARIOHEALTH CORP.

Dario Signs Two Employers for Cardiometabolic Suite with Integrated GLP-1 Solution PR Newswire NEW YORK, April 18, 2024 Dario selected to provide integrated and proven solutions to improve employee cardiometabolic health NEW YORK , April 18, 2024 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO) ("Dario" or the "Company"), a leader in the global digital health market, announced today two new contracts to provide integrated chronic condition management solutions for two employers beginning in the...

Dario Publishes Two New Peer-Reviewed Studies Demonstrating Impact of Digital Behavioral Health PR Newswire NEW YORK, April 10, 2024 Studies include a Randomized Controlled Trial demonstrating significant reduction in perceived stress for teens NEW YORK , April 10, 2024 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO) ("Dario" or the "Company"), a leader in the global digital health market, announced today two new studies published in the leading peer-reviewed journal for digital health and...

Two National Employers Select Dario's Integrated Chronic Condition Solution to Improve Employee Health PR Newswire NEW YORK, April 2, 2024 Dario selected to provide integrated approach to improve employee cardiometabolic health - including support for those taking a GLP-1 medication - musculoskeletal and behavioral health NEW YORK , April 2, 2024 /PRNewswire/ -- DarioHealth Corp. (NASDAQ: DRIO) ("Dario" or the "Company"), a leader in the global digital health market, announced today two new...

DarioHealth Reports Fourth Quarter and Full-Year 2023 Financial and Operating Results PR Newswire NEW YORK, March 28, 2024 Full-year 2023 revenue of $20.4 million reflects a decrease from 2022 revenue of $7.3 due to a managed decrease in B2C and strategic milestone revenue as the core B2B2C revenue increased. 2023 B2B2C, employers and health plans recurring revenues increased 39% year over year as the core business continues to gain traction. Commercial revenues in 2023 generated majority of the...

DARIOHEALTH TO REPORT FOURTH QUARTER 2023 RESULTS ON THURSDAY, MARCH 28TH PR Newswire NEW YORK, March 21, 2024 Company to host conference call and webcast at 8:30am ET NEW YORK , March 21, 2024 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO), a leader in the global digital therapeutics (DTx) market, announced today that it will release its financial results for the 4 th quarter ended December 31, 2023, on Thursday, March 28 th , 2024, before the market opens and will host a conference call and...

New Research from Dario Demonstrates Ability to Deliver Improved Health Outcomes with Integrated Solution for Members Managing Weight and Blood Glucose with or without GLP-1 Medications PR Newswire NEW YORK, March 12, 2024 Study presented at ATTD 2024 is the first of a planned series examining the impact of Dario's integrated cardiometabolic solution as a means to address weight and diabetes with or without a GLP-1 Additional research presented demonstrated Dario's ability to improve awareness...

DARIOHEALTH TO PARTICIPATE IN THE COWEN 43RD ANNUAL HEALTHCARE CONFERENCE PR Newswire NEW YORK, Feb. 28, 2024 NEW YORK , Feb. 28, 2024 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO), a leader in the global digital health market, today announced that management will participate in the Cowen 44 th Annual Healthcare Conference, which is being held March 4-6, 2024 , at the Boston Marriott Copley Place in Boston, Massachusetts . Erez Raphael , Chief Executive Officer, and Rick Anderson , President,...

Dario acquires Twill creating one of the most comprehensive digital health platform across the most prevalent chronic conditions PR Newswire NEW YORK, Feb. 21, 2024 Expecting nearly doubling Dario's pro forma revenues in 2023 Acquisition is immediately accretive to revenue and gross margins and expected to accelerate path to profitability Concurrent with the acquisition Dario prices $22.4 million equity financing Company to host conference call today at 8:30am ET . Dial-in and replay information...

Regional Union Selects Dario's Cardiometabolic Solution for Diabetes, Hypertension, Weight Management and GLP-1 Support PR Newswire NEW YORK, Jan. 11, 2024 Dario's integrated solution to support improved whole health gains traction in public and labor market NEW YORK , Jan. 11, 2024 /PRNewswire/ -- DarioHealth Corp. (NASDAQ: DRIO) ("Dario" or the "Company"), a leader in the global digital health market, announced today a new contract to provide its cardiometabolic solution to a regional union...

National Employer Selects Dario Cardiometabolic and GLP-1 Solutions to Improve Employee Health PR Newswire NEW YORK, Dec. 5, 2023 New client will use Dario's integrated approach to support long-term behavior change for employees living with diabetes, pre-diabetes, hypertension and those taking a GLP-1 medication NEW YORK , Dec. 5, 2023 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO) ("Dario" or the "Company"), a leader in the global digital health market, announced today a new contract to...

Dario Contracts with New Employer for Cardiometabolic Solution PR Newswire NEW YORK, Nov. 27, 2023 Demand for Dario's integrated cardiometabolic solution continues to grow as employers grappling with the surge in GLP-1 medication utilization search for proven ways to change health behaviors NEW YORK , Nov. 27, 2023 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO) ("Dario" or the "Company"), a leader in the global digital health market, announced today a new contract to provide its...

New Research Sheds Light on Mediators of Improved Outcomes in Dario Users PR Newswire NEW YORK, Nov. 21, 2023 Two new analyses associate improved clinical and economic outcomes with use of Dario's digital health solution NEW YORK , Nov. 21, 2023 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO) ("Dario" or the "Company"), a leader in the global digital health market, announced today two new analyses recently presented by Sanofi U.S. demonstrating two mediators associated with improved clinical...

Dario Publishes New Research Demonstrating that Dario Users That Increased Physical Activity Can Maintain Reduced Blood Glucose PR Newswire NEW YORK, Nov. 13, 2023 New study highlights the value of a whole health approach managing chronic conditions and supporting members using GLP-1s NEW YORK , Nov. 13, 2023 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO) ("Dario" or the "Company"), a leader in the global digital health market, announced new research presented at the Diabetes Technology...

DarioHealth Reports Third Quarter 2023 Financial and Operating Results PR Newswire NEW YORK, Nov. 2, 2023 Third quarter total revenue of $3.52 million compared to $6.6 million in the third quarter of 2022, impacted mainly by lower commercial strategic partners revenues in the quarter of $209,000 as compared to $3.1 million in Q3 2022. Third quarter 2023 commercial B2B2C revenues from monthly recurring revenues derived from employers and health plans is up 19.3% over third quarter 2022; nine...

Dario Launches Apple iPhone 15 Accessible Smart Blood Glucose Meter PR Newswire NEW YORK, Nov. 1, 2023 New connectivity expands Dario's advantage with consumer accessibility NEW YORK , Nov. 1, 2023 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO) ("Dario" or the "Company"), a leader in the global digital health market, announced the launch of a new smart blood sugar meter for Apple iPhone 15 users to support ongoing engagement with new and existing members. As recently reported, the new iPhone...

DarioHealth to Report Third Quarter 2023 Results on Thursday, November 2nd PR Newswire NEW YORK, Oct. 30, 2023 Company to host conference call and webcast at 8:30am ET NEW YORK , Oct. 30, 2023 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO), a leader in the global digital health market, today announced that it will release its financial results for the third quarter ended September 30, 2023 , on Thursday, November 2, 2023 , before market opens and will host a conference call and webcast at 8:30...

New Research Shows 36% Reduction in 30-Day Hospital Readmission Rate for Dario Users with Type 2 Diabetes PR Newswire NEW YORK, Oct. 17, 2023 New research demonstrates Dario's ability to reduce costs through lower utilization of expensive healthcare resources, and the winning of a prestigious gold ribbon award NEW YORK , Oct. 17, 2023 /PRNewswire/ -- DarioHealth Corp. (NASDAQ: DRIO) ("Dario" or the "Company"), a leader in the global digital health market, announced today new research presented...

Dario Signs National Preferred Partner Agreement with a Top Five National Employee Benefits Consulting Firm PR Newswire NEW YORK, Oct. 5, 2023 Agreement names Dario as the preferred digital health provider for employer clients NEW YORK , Oct. 5, 2023 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO) ("Dario" or the "Company"), a leader in the global digital health market, announced a new strategic partnership with a top five national employee benefits consulting firm (the "Firm"), to become the...

DarioHealth to Host Investor Day on The Rise of Digital Health PR Newswire NEW YORK, Oct. 3, 2023 In-person event scheduled for Tuesday, October 17, 2023 , in New York NEW YORK , Oct. 3, 2023 /PRNewswire/ -- DarioHealth Corp. (NASDAQ: DRIO) ("Dario" or the "Company"), a leader in the global digital health market, announced that it will host an in-person investor day in New York at the offices of Sullivan & Worcester LLP located at 1633 Broadway, 32 nd floor, on October 17, 2023 at 11:00 AM ET ....

Dario Publishes New Research Demonstrating Clinically Significant Reductions in Depression Through its Digital Behavioral Health Programs PR Newswire NEW YORK, Sept. 27, 2023 63% of members using the Dario platform saw significant reduction in depression and anxiety symptoms NEW YORK , Sept. 27, 2023 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO) ("Dario" or the "Company"), a leader in the global digital health market, announced new research published in the Journal of Medical Internet...